Head-to-Head Supplement Comparison

Prevagen vs. Neuriva (2026): Ingredients, Evidence & Which is Better

Audited By: BrainFort USA Clinical Review Board Published: February 15, 2026 Updated: September 18, 2026 Category: Retail Cognitive Formulations

Executive Comparison Verdict

In the United States pharmacy and retail grocery space (CVS, Walgreens, Walmart, Amazon), Prevagen and Neuriva represent the two best-selling over-the-counter memory supplements. However, their biological mechanisms and clinical evidence bases could not be more divergent:

  • Prevagen relies almost exclusively on Apoaequorin, a jellyfish calcium-binding protein that has been subject to federal regulatory litigation by the FTC and New York Attorney General regarding unsubstantiated memory claims.
  • Neuriva (manufactured by Reckitt Benckiser / Schiff) relies on NeuroFactor (whole coffee fruit extract) and Phosphatidylserine, two compounds with verifiable published peer-reviewed human trials demonstrating increases in Brain-Derived Neurotrophic Factor (BDNF) and cell membrane support.
Clinical Recommendation: Neuriva holds significantly higher scientific validity and evidence-grade support than Prevagen.

1. Formula & Active Ingredient Comparison Matrix

Examining the ingredient labels reveals fundamental differences in formulation philosophy, active constituent transparency, and biological targets:

Feature / Dimension Prevagen (Regular / Extra Strength) Neuriva (Original / Plus)
Primary Active Ingredient(s) Apoaequorin (10 mg to 20 mg) + Vitamin D (50 mcg) NeuroFactor Whole Coffee Fruit Extract (100 mg) + Phosphatidylserine (100 mg) + B-Vitamins (Plus version)
Proposed Mechanism Intracellular calcium buffering in aging neurons BDNF upregulation (neurogenesis) + neuronal membrane phospholipid repair
Blood-Brain Barrier Crossing Unproven / Highly Unlikely (digested as peptides in stomach) Verified (PS crosses BBB; NeuroFactor stimulates peripheral-to-central BDNF signaling)
Human Trial Support Single unpublished manufacturer study ("Madison Memory Study") failed primary endpoints Multiple peer-reviewed RCTs published on NeuroFactor and Phosphatidylserine (Cenacchi, Reyes-Izquierdo)
Regulatory Scrutiny Subject of FTC & NY Attorney General deceptive advertising enforcement Standard DSHEA compliance; resolved class-action label adjustment in 2021
Monthly Cost (Retail) $39.95 (10mg) to $59.95 (20mg) $29.99 (Original) to $44.99 (Plus)

2. The Science of Prevagen: What Does the Evidence Really Show?

Prevagen's marketing leans heavily on television commercials promoting "clinically shown to help with mild memory problems associated with aging." However, scientific scrutiny reveals substantial biological and methodological limitations:

  • Digestive Proteolysis: Apoaequorin is a protein consisting of 189 amino acids. When swallowed orally, gastric pepsin and hydrochloric acid digest it into basic peptide fragments and individual amino acids within 45 seconds of stomach entry. Intact Apoaequorin has never been shown to enter the human bloodstream or cross the blood-brain barrier.
  • The Madison Memory Study: The manufacturer's sole double-blind trial failed to show statistically significant differences on primary cognitive endpoints between the treated group and placebo cohorts. The manufacturer's marketing claims derived entirely from post-hoc subgroup mining (analyzing over 30 post-hoc divisions until a nominal statistical significance appeared), a practice heavily criticized by clinical biostatisticians.

3. The Science of Neuriva: BDNF and Phosphatidylserine

Neuriva takes a markedly more conventional pharmacological approach, pairing two established nootropic compounds:

Key Neurochemical Mechanisms:

  • NeuroFactor (Whole Coffee Cherry): In double-blind human clinical trials (Reyes-Izquierdo et al., 2013), a single 100 mg dose of whole coffee cherry extract resulted in a statistically significant 143% increase in circulating plasma BDNF compared to placebo, stimulating synaptic neuroplasticity.
  • Phosphatidylserine (PS): A structural phospholipid that comprises roughly 15% of the total phospholipid pool in the human cerebral cortex. Decades of clinical trials indicate 100 mg to 300 mg of PS supports cell membrane fluidity, neurotransmitter release, and working memory recall.

4. Side Effects, Drug Interactions & Safety Profiles

Both supplements are non-prescription over-the-counter formulas with relatively benign safety records, but differing contraindications:

  • Prevagen Safety: While Generally Recognized as Safe (GRAS) by the manufacturer, adverse event reporting systems have recorded sporadic complaints of headaches, nausea, dizziness, and sleep disturbance.
  • Neuriva Safety: NeuroFactor contains negligible amounts of caffeine (less than 1 mg per serving, equivalent to a sip of decaf coffee). Phosphatidylserine is exceptionally well-tolerated, with occasional mild gastrointestinal upset at higher doses. Those on blood-thinning pharmaceutical medications should consult their physician before starting PS.

Explore Detailed Memory & Brain Health Monograms

Deepen your evaluation of clinical memory evidence, compare phospholipid science, or review safety guidelines for older adults.

Phosphatidylserine Evidence Guide → Older Adults Safety Guide → Memory Supplements Pillar →